T3 releasing activity by Graves' sera from Graves' thyroid in vitro

Area of Science:

• Endocrinology and Immunology
• Thyroid Research

Background:

• Graves' disease involves thyroid insensitivity to TSH and immunoglobulin stimulation.
• Understanding antibody activity in Graves' thyroid is crucial.

Purpose of the Study:

• Identify Graves' sera that stimulate T3 release from Graves' thyroid tissue in vitro.
• Characterize the determinants responsible for the efficacy of these sera.

Main Methods:

• Tested 20 Graves' sera for T3 release stimulation on Graves' thyroid slices and human goitrous thyroid.
• Assessed TSH binding inhibiting immunoglobulins using a radioreceptor assay.
• Evaluated sera's effect irrespective of patient pretreatment with medications.

Main Results:

• Six out of 20 Graves' sera stimulated T3 release from Graves' thyroid in vitro.
• These stimulating sera showed no enhanced activity on goitrous thyroid tissue.
• Graves' thyroid stimulating sera exhibited low or absent TSH binding inhibiting activity.

Conclusions:

• A subset of Graves' sera can activate hormone release from Graves' thyroid, unlike goitrous tissue.
• These sera possess potent TSH agonistic antibodies with minimal TSH binding inhibition.
• This suggests a specific antibody profile drives thyroid stimulation in some Graves' patients.